namibia
uniqu
found
magnitud
report
elsewher
southern
africa
reason
kudu
appear
except
suscept
rabi
still
remain
specul
best
current
sever
rabi
endem
kudu
continu
enorm
neg
impact
namibian
agricultur
sector
set
question
exist
dogma
regard
epidemiolog
diseas
uniqu
experiment
set
addit
explor
effect
measur
protect
antelop
although
abl
confirm
high
suscept
kudu
rabi
sporad
horizont
rabi
viru
transmiss
contact
anim
contend
observ
plausibl
explain
rapid
spread
diseas
kudu
larg
territori
sinc
parenter
vaccin
freeroam
kudu
virtual
imposs
oral
rabi
vaccin
use
modifi
life
viru
vaccin
high
safeti
profil
would
ultim
solut
problem
proofofconcept
studi
use
gener
oral
rabi
viru
vaccin
construct
spbn
gasga
found
evid
kudu
vaccin
oral
rout
protect
subsequ
rabi
infect
second
phase
target
studi
need
initi
focus
optim
oral
vaccin
uptak
deliveri
anim
hous
condit
adult
freeliv
kudu
n
caught
mass
captur
individu
dart
helicopt
game
farm
three
differ
conserv
transport
experiment
hold
facil
okosongoro
safari
ranch
locat
km
northwest
windhoek
fig
blood
sampl
taken
day
captur
assess
immunolog
statu
anim
separ
group
anim
gender
hous
two
attach
pen
boma
boma
consist
cover
open
area
could
separ
slide
door
area
could
enter
separ
also
slide
door
could
use
connect
pen
adjac
pen
separ
singl
anim
height
indoor
part
pen
outdoor
section
surround
high
wall
larg
door
open
direct
connect
pen
central
passag
overhead
catwalk
enabl
staff
observ
anim
facilit
separ
manipul
anim
eg
immobil
vaccin
infect
blood
sampl
purpos
studi
prevent
contact
freeroam
wildlif
adjac
area
entir
experiment
hold
facil
surround
area
secur
singl
high
wire
mesh
game
proof
fenc
fig
furthermor
anim
held
experiment
facil
entir
studi
period
site
guard
h
per
day
anim
feed
prophylact
treatment
upon
arriv
kudu
treat
doramectin
dectomax
solut
pfizer
sandton
south
africa
intern
extern
parasit
receiv
multivitamin
prepar
kyrovit
b
co
super
kyron
johannesburg
south
africa
metabol
stimul
inject
kyropho
metabolicv
kyron
period
confin
anim
receiv
diet
lucern
straw
medicago
sativa
game
cube
bosko
wesenterpris
thabazimbi
south
africa
supplement
pod
camel
thorn
tree
acacia
erioloba
umbrella
thorn
tree
acacia
tortili
suppli
bosko
exhaust
replac
standard
game
cube
altern
game
cube
plu
ivermectin
feedmast
windhoek
namibia
provis
acacia
pod
particularli
reduc
hot
dri
season
fruit
becam
unobtain
pen
clean
daili
remov
drop
uneaten
feed
transmiss
studi
transmiss
studi
total
kudu
tabl
held
one
group
six
anim
group
group
five
anim
group
bd
tabl
prior
infect
anim
adapt
captiv
day
period
one
anim
group
infect
high
tcid
n
dose
anoth
anim
inocul
low
tcid
n
dose
kudu
rabi
viru
isol
see
remain
conspecif
serv
contact
anim
group
n
group
bd
n
tabl
challeng
viru
administ
intramuscular
im
inject
bilater
masset
muscl
volum
ml
per
site
upon
infect
anim
observ
least
twice
daili
period
prevent
contact
freeroam
wildlif
adjac
area
entir
experiment
hold
facil
surround
area
secur
singl
high
wire
mesh
game
proof
fenc
overhead
catwalk
enabl
staff
better
observ
manipul
anim
b
individu
pen
boma
consist
cover
open
area
c
slide
door
could
use
connect
pen
adjac
pen
separ
singl
anim
height
indoor
part
pen
outdoor
section
surround
high
wall
day
develop
clinic
sign
record
fig
accord
anim
welfar
protocol
immedi
onset
first
clinic
sign
anim
sedat
human
euthan
supervis
veterinarian
overdos
thiafentanil
oxal
mgml
thianil
wildlif
pharmaceut
windsor
usa
clinic
sign
includ
bellow
throw
head
back
persist
swallow
movement
persist
lick
paresi
paralysi
hypersaliv
froth
mouth
point
survivor
eartag
vaccin
parenter
rabi
rehom
spot
end
observ
period
vaccin
studi
twenti
five
kudu
use
vaccin
studi
held
group
four
anim
one
group
five
anim
tabl
prior
vaccin
anim
allow
adapt
captiv
day
ten
anim
femal
male
three
group
receiv
approx
ml
oral
rabi
viru
vaccin
construct
spbn
gasga
ffuml
direct
oral
administr
doa
posit
control
femal
kudu
divid
group
receiv
ml
commerci
inactiv
rabi
vaccin
rabisin
merial
franc
im
rout
tabl
vaccin
anim
challeng
day
togeth
anim
transmiss
studi
day
post
vaccin
pv
high
dose
tcid
kudu
rabv
isol
use
rout
administr
follow
termin
criteria
describ
surviv
vaccin
anim
follow
studi
period
day
post
infect
pi
fig
sampl
serum
sampl
b
collect
differ
time
point
prior
pv
pi
investig
develop
kinet
rabi
induc
antibodi
fig
initi
blood
sampl
day
captur
addit
blood
sampl
taken
day
p
postul
overexpress
rabv
g
increas
efficaci
also
safeti
profil
reduc
potenti
risk
revers
virul
enhanc
apoptosi
vaccin
viru
propag
bsr
cell
harvest
hour
cellcultur
vaccin
materi
subsequ
time
ultrafiltr
stabil
ml
antigen
ml
reach
final
titr
ffuml
challeng
rabv
viru
use
lab
id
initi
isol
brain
natur
infect
kudu
genbank
access
genet
character
three
serial
passag
mous
neuroblastoma
cell
inoculum
titr
micld
ml
tcid
ml
assay
intracerebr
inocul
mice
cell
cultur
respect
verif
genet
ident
rabv
isol
passag
cell
cultur
use
next
gener
sequenc
reveal
addit
insert
three
nucleotid
posit
aac
intergen
region
phosphoprotein
p
matrix
protein
gene
specif
sequenc
variat
confirm
convent
sanger
sequenc
two
independ
pcr
amplicon
supplementari
materi
let
extens
transcript
stop
signal
addit
follow
intergen
region
start
addit
c
compris
nucleotid
nt
inform
consent
experi
involv
human
particip
includ
use
human
tissu
sampl
therefor
inform
consent
need
diagnost
assay
presenc
rabv
antigen
brain
tissu
kudu
detect
fluoresc
antibodi
test
fat
describ
previous
use
polyclon
oierl
onderstepoort
south
africa
commerci
fitclabel
monoclon
sifin
berlin
germani
antirabi
antibodi
defin
posit
pc
posit
fox
brain
neg
control
nc
cattl
brain
includ
everi
test
run
fat
indetermin
result
confirm
realtim
polymeras
chain
reaction
rtqpcr
rabi
tissu
cultur
infect
test
rtcit
latter
three
consecut
passag
confirm
neg
result
sera
test
presenc
rabi
specif
antibodi
use
three
differ
serolog
assay
modifi
cutoff
viru
neutral
antibodi
vna
detect
modifi
rapid
fluoresc
focu
inhibit
test
rffit
essenti
describ
use
calibr
intern
standard
immunoglobulin
human
rabi
immunoglobulin
prepar
nation
institut
standard
control
potter
bar
uk
adjust
intern
unit
iu
naiv
bovin
serum
pc
nc
respect
vna
titr
calcul
use
invers
interpol
describ
express
intern
unit
iuml
presenc
rabi
specif
bind
antibodi
test
use
commerci
block
elisa
biopro
rabi
elisa
czech
republ
strictli
follow
manufactur
instruct
studi
evalu
elisa
kit
found
specif
sensit
fox
raccoon
dog
sera
concord
assay
measur
vna
fluoresc
antibodi
neutral
test
none
serolog
assay
employ
studi
fulli
evalu
kudu
sera
previou
public
demonstr
variabl
cutoff
level
per
speci
account
lack
uniqu
identifi
cutoff
assay
kudu
sera
besid
seroposit
seroneg
result
indetermin
valu
consid
within
rang
variat
around
presum
cutoff
posit
iuml
iuml
rffit
biopro
elisa
describ
previous
versatil
practic
method
measur
rabi
specif
antibodi
pv
addit
rapina
test
appli
rd
method
follow
instruct
manufactur
final
score
serum
sampl
deem
antibodi
neg
posit
base
weight
analysi
result
obtain
differ
assay
without
give
absolut
valu
elisa
rffit
result
given
weight
rapina
test
latter
consid
standard
test
rabi
serolog
yet
wherebi
seroposit
seroneg
indetermin
everi
receiv
score
everi
score
total
score
calcul
ad
valu
neg
score
consid
seroneg
posit
score
seroposit
fat
test
done
parallel
central
veterinari
laboratori
cvl
windhoek
friedrichloefflerinstitut
fli
greifswaldinsel
riem
rtqpcr
rtcit
serolog
assay
exclus
conduct
fli
end
experiment
studi
infer
statist
differ
serolog
result
fisher
exact
test
appli
wherea
surviv
rate
mantelcox
test
logrank
test
use
implement
graphpad
prism
version
graphpad
softwar
la
jolla
california
usa
pvalu
consid
signific
ill
sever
injuri
fractur
result
captur
stress
anim
remov
variou
time
throughout
studi
one
anim
transmiss
group
anim
vaccin
group
day
prior
infect
tabl
releas
anim
back
wild
could
justifi
reason
anim
welfar
human
euthan
none
anim
show
clinic
sign
suggest
rabi
transmiss
studi
four
anim
inocul
high
dose
kudu
rabv
isol
tcid
seroneg
succumb
infect
day
pi
one
low
dose
infect
kudu
die
euthan
day
pi
tabl
fig
two
latter
anim
rabi
specif
antibodi
tabl
kudu
surviv
low
dose
challeng
viru
infect
seroconvert
day
pi
clinic
sign
includ
swallow
movement
associ
moder
saliv
paresi
mild
froth
mouth
two
case
remain
anim
group
mostli
tri
stay
away
avoid
contact
display
clinic
sign
six
anim
succumb
infect
fat
posit
two
regard
fat
inconclus
latter
two
posit
rtqpcr
two
contact
anim
surviv
day
observ
period
two
contact
anim
die
day
pi
howev
latter
viral
antigen
rna
detect
fat
pcr
respect
tabl
fig
sequenc
rabv
isol
fat
posit
contact
anim
reveal
sequenc
ident
challeng
viru
includ
insert
survivor
tabl
fig
three
contact
anim
rate
antibodi
posit
remain
seroposit
observ
period
day
contrastingli
three
surviv
contact
anim
consid
seroneg
begin
studi
seroconvert
tabl
fig
signific
differ
fisher
exact
test
p
parenter
versu
doa
vaccin
group
gener
doa
vaccin
anim
show
fold
increas
elisa
mean
pb
valu
day
pv
compar
day
remain
elisa
cutoff
posit
though
fold
increas
compar
day
gmt
vna
oral
vaccin
anim
remain
iuml
challeng
tabl
fig
kudu
vaccin
oral
rout
surviv
challeng
tabl
fig
two
anim
remain
seroneg
prior
infect
one
kudu
detect
level
antibodi
time
point
captur
turn
seroneg
day
pv
challeng
infect
three
survivor
develop
high
level
rabi
specif
antibodi
gmt
individu
anim
increas
iuml
day
pi
resembl
fold
increas
compar
day
day
pv
respect
tabl
fig
initi
seroneg
time
point
captur
doa
vaccin
kudu
succumb
infect
two
anim
develop
rabi
specif
antibodi
pv
anim
die
day
pi
tabl
fig
six
anim
fatposit
one
fatneg
anim
test
posit
rtpcr
logrankmantelcox
test
p
differ
surviv
curv
oral
vaccin
vs
high
dose
infect
anim
transmiss
studi
countri
world
larg
popul
kudu
namibia
high
popul
densiti
result
game
farm
thought
favor
rabi
epidem
among
speci
experi
involv
larg
highli
stresssensit
wildcaught
speci
like
kudu
typic
limit
space
cost
also
lack
suitabl
research
facil
abl
hous
larg
antelop
quarantin
condit
restrict
studi
rel
remot
hold
site
normal
use
temporari
hous
wild
game
sale
auction
henc
complic
observ
sampl
sampl
storag
transport
precaut
safeti
measur
specif
develop
purpos
studi
high
standard
proven
use
prevent
contact
freeroam
wildlif
adjac
area
fig
rel
short
incub
period
day
observ
high
dose
infect
within
lower
bound
expect
rang
compar
carnivor
reservoir
speci
kudu
cattl
extrem
long
incub
period
day
low
dose
infect
remark
particularli
background
rout
infect
fact
differ
viral
dose
two
log
step
fig
howev
long
incub
period
use
similar
dose
also
report
skunk
golden
jackal
raccoon
fox
addit
outcom
transmiss
studi
show
depend
viral
dose
kudu
abl
surviv
infect
rabv
henc
confirm
previou
observ
anim
surviv
infect
never
show
clinic
sign
indic
viru
recogn
clear
immun
system
either
prior
movement
peripher
nerv
prior
infect
central
nervou
system
find
may
also
explain
sever
anim
seroposit
day
captur
tabl
sheer
magnitud
epizoot
phylogenet
data
believ
support
horizont
transmiss
mainten
rabi
cycl
within
speci
howev
despit
anecdot
evid
horizont
rabi
transmiss
among
kudu
day
hypothesi
still
definit
confirm
larger
experiment
set
hypothesi
base
observ
hypersaliv
high
viral
titr
saliva
rabid
kudu
groom
habit
particular
experiment
studi
although
artifici
exposur
infect
show
kudu
die
rabi
experiment
infect
instil
infect
saliva
onto
buccal
mucosa
intranas
infect
exclud
provok
diseas
saliva
also
instil
nasal
caviti
time
fact
administr
effect
way
deliv
rabv
directli
brain
via
olfactori
nerv
studi
seem
corrobor
possibl
horizont
transmiss
viru
isol
contact
anim
possess
uniqu
marker
challeng
strain
use
sinc
length
stop
signal
intergen
region
affect
polymeras
termin
downstream
reiniti
potenti
effect
three
nt
insert
intergen
region
p
gene
viru
replic
exclud
howev
sinc
select
addit
insert
cours
limit
cell
cultur
passag
like
support
viru
replic
glycoprotein
identifi
major
pathogen
factor
major
effect
virul
challeng
viru
unlik
also
observ
contact
anim
consid
seroneg
time
point
captur
seroconvert
day
pi
tabl
could
consid
evid
exposur
infecti
saliva
inocul
kudu
succumb
diseas
unfortun
relationship
dose
strength
prime
use
street
rabv
well
character
bat
wildlif
although
experiment
set
allow
natur
social
feed
behavior
greatest
possibl
extent
kudu
human
euthan
earli
show
clinic
sign
may
limit
likelihood
success
onward
transmiss
lead
horizont
acquir
rabi
fact
one
contact
anim
die
rabi
need
care
interpret
observ
resembl
natur
occur
infect
would
suggest
extent
horizont
transmiss
field
condit
less
actual
believ
even
transmiss
rate
underestim
acquir
seroposit
contact
anim
tabl
also
consid
evid
transmiss
latter
highli
debat
local
horizont
transmiss
plausibl
explain
recent
epidem
rapid
spread
diseas
kudu
larg
territori
sens
long
incub
period
might
add
situat
explain
rabi
kudu
resurg
month
area
believ
disappear
interestingli
high
number
cattl
rabi
case
small
rumin
area
kudu
rabi
endem
unpublish
also
bring
question
role
kudu
sole
reservoir
phylogenet
work
scott
cowork
seem
support
evid
independ
horizont
transmiss
among
kudu
contradict
earlier
studi
suggest
jackal
kudu
may
form
part
epidemiolog
cycl
rabi
namibian
wildlif
epidemiolog
point
view
combin
spillov
event
perhap
local
restrict
horizont
transmiss
exclud
howev
consid
discuss
thu
far
also
epidemiolog
aspect
includ
manag
transloc
natur
movement
behavior
paramet
would
definit
need
thorough
investig
consider
unravel
mysteri
kudu
rabi
namibia
expand
concept
oral
vaccin
rabi
success
develop
wild
carnivor
kudu
seem
feasibl
approach
consid
commerci
product
oral
immun
rumin
alreadi
exist
eg
immun
calv
control
diarrhea
caus
bovin
rotaviru
coronaviru
calfguard
zoeti
howev
mucos
immun
oral
deliveri
often
compromis
antigen
degrad
stomach
especi
consid
complex
gastrointestin
tract
larger
rumin
therefor
assur
antigen
uptak
peyer
patch
intestin
addit
substanc
often
ad
oral
vaccin
formul
protect
antigen
enzymat
proteolyt
degrad
howev
gut
site
mucousassoci
lymphoid
tissu
malt
contain
lymphoid
follicl
mcell
malt
also
found
nasal
oral
caviti
wherebi
tonsil
form
major
compon
latter
recent
studi
indic
oral
vaccin
mesocarnivor
rabi
palatin
tonsil
major
site
vaccin
uptak
palatin
tonsil
also
present
rumin
like
cattl
sheep
goat
experiment
studi
wild
rumin
like
whitetail
deer
odocoileu
virginianu
show
doa
bcgvaccin
target
pharyng
lymphoid
tissu
abl
induc
immun
respons
bovin
tuberculosi
also
oral
administr
heatinactiv
mycobacterium
bovi
red
deer
cervu
elaphu
induc
level
protect
bovin
tuberculosi
proofofprincipl
experi
anim
oral
vaccin
spbn
gsaga
surviv
sever
rabi
challeng
infect
high
challeng
dose
tabl
fig
even
though
statist
signific
surviv
unvaccin
doa
vaccin
anim
found
surviv
kudu
suggest
oral
vaccin
may
elicit
protect
immun
respons
speci
interestingli
none
anim
surviv
detect
level
antibodi
assay
elisa
rapina
rffit
pv
howev
strong
immun
respons
pi
clear
evid
primeboost
effect
tabl
fig
must
mention
vaccin
viru
evenli
distribut
oral
caviti
kudu
use
needleless
syring
simul
releas
vaccin
chew
vaccin
sachet
palatin
tonsillar
crypt
potenti
uptak
site
specif
target
howev
unfortun
spillag
vaccin
viru
could
prevent
anesthet
includ
thiafentanil
oxal
induc
saliv
wild
herbivor
combin
grind
often
produc
froth
around
mouth
per
se
make
doa
speci
difficult
hand
one
argu
surviv
oral
vaccin
kudu
tabl
fig
challeng
appear
convinc
howev
first
time
proofofconcept
studi
ever
conduct
herbivor
speci
kudu
vaccin
strain
spbn
gasga
shown
efficaci
sever
anim
speci
like
red
fox
vulp
vulp
raccoon
dog
nyctereut
procyonoid
raccoon
procyon
lotor
small
indian
mongoos
herpest
auropunctatu
howev
stripe
skunk
mephiti
mephiti
seem
rather
refractori
vaccin
oral
rout
vaccin
viru
titer
depend
manner
exclud
could
also
appli
kudu
perform
serolog
assay
use
interpret
serolog
result
obtain
present
problem
rffit
oie
recommend
test
detect
vna
respons
vaccin
human
anim
particularli
connect
intern
travel
pet
elisa
rapina
test
develop
qualit
semiquantit
detect
rabi
antibodi
fox
raccoon
dog
human
dog
respect
none
serolog
assay
howev
valid
kudu
therefor
modifi
threshold
posit
introduc
addit
grey
zone
inconclus
indetermin
result
base
analysi
moor
et
al
subsequ
weight
score
allow
clear
identif
sera
seroposit
neg
without
give
absolut
valu
avoid
classifi
sera
indetermin
note
addit
result
anoth
elisa
platelia
ii
biorad
tabl
exclud
analysi
protein
bind
well
igg
bovin
equin
speci
use
approach
result
obtain
pv
anim
vaccin
parenter
rout
show
perfect
correl
seroconvers
protect
serolog
assay
howev
anim
receiv
vaccin
oral
rout
serolog
result
difficult
interpret
tabl
fig
see
doa
vaccin
seroneg
anim
surviv
challeng
two
kudu
supposedli
acquir
preexist
antibodi
day
challeng
succumb
infect
indic
nonprotect
immun
tabl
perhap
measur
humor
antibodi
respons
prior
challeng
suffici
specif
associ
cellular
immun
prevent
lethal
infect
result
studi
somewhat
corrobor
result
obtain
studi
rabi
repeat
challeng
bat
suggest
singl
exposur
may
protect
kudu
significantli
subsequ
infect
find
also
underscor
diagnost
assay
valid
specif
sensit
sampl
certain
speci
automat
suitabl
sampl
speci
recent
shown
serolog
moor
et
al
kudu
vaccin
oral
rout
protect
subsequ
rabi
infect
although
seem
rather
refractori
rout
vaccin
administr
case
studi
need
initi
optim
oral
vaccin
uptak
deliveri
rd
gener
attenu
oral
rabi
vaccin
altern
recombin
rabi
viru
vaccin
express
rabv
glycoprotein
could
also
consid
futur
studi
time
minimum
effect
titer
attenu
recombin
vaccin
virus
requir
effici
immun
anim
known
yet
henc
research
investig
vaccin
uptak
effect
improv
exampl
increas
vaccin
titr
vaccin
interv
ad
mucoadhes
substanc
attract
bait
oral
vaccin
kudu
develop
alreadi
howev
bait
deliveri
system
need
optim
case
vaccin
potenc
enhanc
speci
also
valid
serolog
assay
kudu
requir
make
better
inform
decis
immun
statu
